0001638599-17-000609.txt : 20170616 0001638599-17-000609.hdr.sgml : 20170616 20170616110748 ACCESSION NUMBER: 0001638599-17-000609 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kay Robert CENTRAL INDEX KEY: 0001285612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 17915109 MAIL ADDRESS: STREET 1: C/O IBIO, INC. STREET 2: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 FORMER NAME: FORMER CONFORMED NAME: KAY ROBERT DATE OF NAME CHANGE: 20040331 4 1 doc4_4800.xml PRIMARY DOCUMENT X0306 4 2017-05-01 0 0001420720 iBio, Inc. IBIO 0001285612 Kay Robert C/O IBIO, INC. 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022 1 1 0 0 Executive Chairman and CEO Stock Option (right to buy) 0.40 2017-05-01 4 A 0 300000 0.40 A 2027-05-01 Common Stock 300000 4350000 D Vests in equal annual installments over three years beginning 12/1/16. /s/ Robert B. Kay 2017-06-16